EZH2 and posterior cortical atrophy: It is well established that up-regulation of EZH2 is closely correlated with the progression of advanced PCa and unfavorable outcome, but the EZH2 inhibitors-based treatment is basically ineffective for PCa (Deb et al., 2013).